Molecular pathogenesis of Merkel cell carcinoma
$638,498ZIAFY2012CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Paper 34208349Paper 34193920Paper 33800889Paper 32753470Paper 31218705Paper 30541782Paper 30287935Paper 29721394Paper 28340681Paper 28130073Paper 27262710Paper 26299616Paper 26022453Paper 25521454Paper 23652945
Abstract
To identify genetic alterations present in Merkel cell carcinoma, we have conducted molecular analyses of human tumors across multiple genome-wide platforms to assay gene expression, identify gene mutations and characterize chromosomal alterations. These data are being analyzed to identify key driver alterations for this tumor. We have also generating mice where oncogenic modifications are carried out in specific skin lineages in an attempt to transform Merkel cells in vivo. In addition we are developing and characterizing cancer cell lines of Merkel cell carcinoma for in vitro and xenograft studies. Finally we are conducting a genetic knockdown screen to identify pathways important for tumor survival.
View original record on NIH RePORTER →